Skip to main content

Published locations for EADV: Secukinumab shows sustained high efficacy in SCULPTURE through 3 years

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. EADV: Secukinumab shows sustained high efficacy in SCULPTURE through 3 years

User login

  • Reset your password
  • /content/eadv-secukinumab-shows-sustained-high-efficacy-sculpture-through-3-years
  • /edermatologynews/article/103965/psoriatic-arthritis/eadv-secukinumab-shows-sustained-high-efficacy
  • /rheumatologynews/article/103965/psoriatic-arthritis/eadv-secukinumab-shows-sustained-high-efficacy
  • /rheumatology/article/103965/psoriatic-arthritis/eadv-secukinumab-shows-sustained-high-efficacy
  • /dermatology/article/103965/psoriatic-arthritis/eadv-secukinumab-shows-sustained-high-efficacy
  • /rheumatology/psoriatic-arthritis-resource-center/article/103965/psoriatic-arthritis/eadv-secukinumab
  • /dermatology/psoriasiscollection/article/103965/psoriatic-arthritis/eadv-secukinumab-shows-sustained
  • /psoriatic-arthritis-icymi/article/103965/psoriatic-arthritis/eadv-secukinumab-shows-sustained-high